Compare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMM

Active, not recruitingOBSERVATIONAL

Enrollment

1,600

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Myeloma Multiple

Interventions

DRUG

Immunotherapy

Trial Locations (1)

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul

All Listed Sponsors

lead

Seoul St. Mary's Hospital

OTHER

NCT06205823 - Compare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMM | Biotech Hunter | Biotech Hunter